Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Cleveland › NPI 1619980430
Lab

University Hospitals Laboratory Services Foundation

University Hospitals Laboratory Services Foundation was paid $41.07M by Medicaid between Jan 2018 and Dec 2024, across 349 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 8.5% of everything it billed.

33Billing provider infoUNIVERSITY HOSPITALS LABORATORY SERVICES FOUNDATION
CLEVELAND, OH 44106
33aNPI1619980430assigned 08/14/2006
33bProvider typeClinical Medical Laboratory
28Total paid$41.07M
24GClaims3,611,003
24DCodes billed349
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Ohio

Rank by total paid#8 of 116
Median peer was paid$313K
This provider vs. median131×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018360,567$4.14M
2019387,073$4.15M
2020383,589$4.76M
2021508,649$7.26M
2022589,857$8.04M
2023728,465$7.04M
2024incomplete652,803$5.67M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 8.5% 81,620 78,816 $3.49M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 6.1% 96,075 91,972 $2.50M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 6.0% 92,313 88,253 $2.45M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 4.1% 12,728 12,390 $1.67M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.9% 42,536 35,925 $1.62M
84443 Thyroid stimulating hormone (TSH) 3.6% 147,730 140,318 $1.49M
80053 Comprehensive metabolic panel 3.5% 206,758 192,064 $1.45M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3.3% 54,871 52,204 $1.37M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3.3% 93,319 88,876 $1.37M
80061 Lipid panel 2.7% 129,775 124,076 $1.10M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.2% 50,252 47,757 $888K
36415 Collection of venous blood by venipuncture 2.0% 321,579 285,618 $830K
337 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.0% 162,254 $822K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.6% 5,370 $673K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.5% 12,597 $635K
85027 1.5% 144,531 $629K
83036 Hemoglobin; glycosylated (A1C) 1.5% 107,094 $625K
86003 1.5% 51,975 $603K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.3% 25,611 $548K
86235 1.3% 25,313 $538K
86780 1.2% 49,391 $482K
86481 1.2% 8,268 $482K
87086 Culture, bacterial; quantitative colony count, urine 1.1% 82,085 $462K
82607 1.1% 45,533 $451K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.0% 7,923 $419K
88185 <1% 6,161 $376K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 19,666 $367K
87506 <1% 2,553 $351K
86803 <1% 34,949 $341K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 10,705 $340K
82728 <1% 38,407 $336K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 13,915 $335K
83655 <1% 32,140 $315K
87800 <1% 8,910 $268K
83970 <1% 10,995 $256K
84439 <1% 44,190 $247K
87340 <1% 33,836 $243K
83550 <1% 36,499 $200K
80048 Basic metabolic panel (calcium, ionized) <1% 35,956 $193K
82746 <1% 19,525 $193K
86317 <1% 9,547 $184K
87536 <1% 3,454 $179K
81229 <1% 335 $162K
87634 <1% 4,048 $157K
84403 <1% 8,984 $157K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,406 $157K
83540 <1% 37,393 $154K
80069 <1% 35,194 $153K
83021 <1% 11,378 $152K
87077 <1% 24,311 $150K
86762 <1% 13,580 $148K
84153 <1% 13,143 $146K
87081 <1% 28,063 $143K
80346 <1% 10,008 $142K
87186 <1% 23,700 $134K
86850 <1% 21,457 $132K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 1,290 $129K
84402 <1% 6,974 $124K
84702 <1% 12,259 $123K
80361 <1% 10,071 $123K
87522 Neg quan hep c or qual rna <1% 4,303 $114K
87529 <1% 2,875 $113K
86140 <1% 31,190 $111K
86038 <1% 13,184 $108K
88184 <1% 4,973 $106K
83880 <1% 4,676 $104K
82570 <1% 36,031 $102K
84146 <1% 7,369 $101K
83735 <1% 29,878 $101K
83001 <1% 8,254 $100K
83516 <1% 11,010 $96K
83002 <1% 6,886 $91K
80197 <1% 18,369 $91K
82670 <1% 4,541 $88K
80050 General health panel <1% 6,278 $88K
82785 <1% 7,534 $87K
87205 <1% 26,896 $82K
83718 <1% 13,935 $81K
84481 <1% 6,751 $78K
83013 <1% 1,707 $77K
80076 <1% 14,718 $77K
82784 <1% 7,339 $74K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,400 $74K
82043 <1% 19,388 $71K
86665 <1% 4,647 $70K
87799 <1% 6,279 $67K
86160 <1% 7,009 $67K
82627 <1% 4,187 $67K
84445 <1% 1,774 $63K
87902 <1% 321 $63K
86225 <1% 7,342 $63K
80074 <1% 3,689 $62K
87070 <1% 9,998 $62K
86706 <1% 9,175 $60K
87497 <1% 4,081 $57K
85652 <1% 30,746 $57K
81001 <1% 27,644 $57K
87075 <1% 7,509 $49K
82024 <1% 1,972 $48K
86376 <1% 4,831 $48K
86900 <1% 22,437 $48K
86901 <1% 22,389 $47K
82533 <1% 4,307 $47K
82465 <1% 14,415 $46K
84425 <1% 3,189 $44K
85045 <1% 14,112 $44K
86147 <1% 1,060 $44K
82652 <1% 2,255 $43K
87631 <1% 524 $42K
84550 <1% 13,626 $41K
84480 <1% 4,154 $41K
82950 <1% 11,132 $40K
83498 <1% 2,045 $40K
81025 <1% 6,435 $39K
88342 <1% 883 $38K
85610 <1% 17,714 $38K
86787 <1% 4,462 $37K
86832 <1% 306 $37K
86664 <1% 3,809 $36K
86696 <1% 2,707 $36K
86704 <1% 5,216 $35K
86833 <1% 297 $34K
83525 <1% 4,149 $34K
83690 <1% 7,299 $34K
83993 <1% 2,385 $34K
86431 <1% 8,832 $34K
86200 <1% 3,874 $33K
84156 <1% 15,019 $33K
81003 <1% 21,616 $33K
86663 <1% 3,816 $32K
84460 <1% 9,626 $32K
86146 <1% 874 $32K
82248 <1% 9,692 $31K
86480 <1% 572 $31K
82105 <1% 3,162 $31K
86800 <1% 2,982 $31K
84450 <1% 8,378 $30K
87102 <1% 4,655 $30K
86364 <1% 3,325 $29K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 1,376 $29K
81381 <1% 389 $28K
86765 <1% 2,983 $28K
80348 <1% 3,798 $27K
86735 <1% 2,798 $27K
86334 <1% 2,020 $25K
82977 <1% 5,420 $25K
80324 <1% 4,191 $25K
84305 <1% 1,605 $25K
86695 <1% 2,712 $25K
88142 <1% 1,740 $25K
82550 <1% 5,667 $25K
84681 <1% 2,246 $25K
86039 <1% 3,157 $24K
82247 <1% 7,562 $24K
87493 <1% 1,587 $24K
83615 <1% 5,647 $23K
82565 <1% 6,644 $23K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 70 $22K
82150 <1% 5,159 $22K
86790 <1% 1,834 $22K
83520 <1% 1,434 $22K
85730 <1% 8,501 $22K
86769 <1% 580 $21K
80365 <1% 4,500 $21K
80354 <1% 4,199 $20K
84100 <1% 7,237 $20K
80373 <1% 4,075 $20K
86008 <1% 1,775 $20K
84165 <1% 3,142 $20K
80349 <1% 3,378 $19K
84630 <1% 2,403 $18K
87328 <1% 1,942 $18K
82947 <1% 7,265 $18K
84207 <1% 1,023 $18K
86258 <1% 1,664 $17K
84144 <1% 1,215 $17K
86255 <1% 1,685 $16K
82525 <1% 2,038 $16K
87209 <1% 1,237 $16K
86708 <1% 2,084 $16K
87632 <1% 137 $15K
80358 <1% 3,572 $15K
80368 <1% 3,543 $15K
82397 <1% 1,312 $15K
86141 <1% 1,621 $15K
84590 <1% 1,696 $13K
84432 <1% 1,265 $13K
84075 <1% 3,980 $13K
80164 <1% 1,550 $13K
82951 <1% 1,728 $12K
83519 <1% 1,045 $12K
84436 <1% 2,970 $12K
83721 <1% 2,791 $11K
85018 <1% 6,474 $11K
84154 <1% 996 $11K
87329 <1% 2,001 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 561 $11K
86870 <1% 560 $11K
86644 <1% 1,522 $11K
85014 <1% 5,533 $10K
87450 <1% 1,110 $10K
84520 <1% 3,577 $9K
87177 <1% 1,367 $9K
88112 <1% 400 $9K
82140 <1% 1,005 $8K
80177 <1% 992 $8K
82378 <1% 837 $8K
86592 <1% 2,650 $8K
84155 <1% 3,754 $8K
87467 <1% 1,496 $8K
83921 <1% 606 $8K
86381 <1% 520 $7K
82103 <1% 957 $7K
80353 <1% 796 $7K
86618 <1% 656 $7K
86694 <1% 636 $7K
82390 <1% 971 $7K
82653 <1% 467 $6K
85379 <1% 1,013 $6K
83020 <1% 662 $6K
87210 <1% 2,098 $6K
86645 <1% 488 $6K
82330 <1% 820 $5K
87505 <1% 173 $5K
83883 <1% 462 $5K
85613 <1% 763 $5K
82610 <1% 384 $5K
87206 <1% 1,323 $5K
83521 <1% 668 $5K
80345 <1% 498 $5K
86705 <1% 661 $5K
84484 <1% 615 $5K
86015 <1% 696 $5K
83010 <1% 520 $4K
82952 <1% 1,789 $4K
84270 <1% 278 $4K
84478 <1% 1,144 $4K
86256 <1% 448 $4K
82157 <1% 182 $4K
36416 <1% 1,172 $4K
86341 <1% 244 $3K
87449 <1% 418 $3K
82672 <1% 228 $3K
86036 <1% 436 $3K
84479 <1% 853 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 131 $3K
84446 <1% 381 $3K
87517 <1% 127 $3K
86162 <1% 251 $3K
84466 <1% 415 $3K
82088 <1% 122 $3K
80158 <1% 483 $3K
87015 <1% 653 $3K
80323 <1% 857 $3K
85007 <1% 1,431 $3K
87040 <1% 447 $3K
86812 <1% 169 $3K
86308 <1% 703 $3K
80178 <1% 690 $3K
87521 Neg quan hep c or qual rna <1% 123 $2K
83090 <1% 263 $2K
82657 <1% 112 $2K
81243 <1% 113 $2K
87084 <1% 460 $2K
88304 <1% 115 $2K
82542 <1% 151 $2K
85246 <1% 132 $2K
87109 <1% 199 $2K
82274 <1% 172 $2K
86318 <1% 285 $2K
84134 <1% 227 $2K
82379 <1% 135 $2K
86593 <1% 675 $2K
84166 <1% 227 $2K
82164 <1% 201 $2K
81509 <1% 46 $2K
82310 <1% 535 $2K
82017 <1% 118 $2K
86001 <1% 184 $2K
86301 <1% 170 $2K
84244 <1% 122 $2K
88341 <1% 91 $2K
87184 <1% 255 $2K
86880 <1% 411 $2K
82787 <1% 86 $1K
80175 <1% 165 $1K
86304 <1% 127 $1K
82104 <1% 152 $1K
84132 <1% 484 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 27 $1K
87900 <1% 12 $1K
82626 <1% 73 $1K
80047 <1% 159 $1K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 28 $1K
87106 <1% 116 $994.01
82139 <1% 63 $937.06
87476 <1% 42 $905.77
86774 <1% 82 $839.29
84703 <1% 155 $818.82
83835 <1% 72 $811.82
87185 <1% 319 $741.81
80202 <1% 96 $711.88
82040 <1% 300 $682.08
84080 <1% 70 $639.56
83605 <1% 82 $611.67
82085 <1% 96 $594.25
82172 <1% 47 $537.58
86825 <1% 16 $492.72
86335 <1% 31 $468.45
81050 <1% 225 $449.48
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 2,056 $371.61
84300 <1% 118 $351.88
82270 <1% 112 $345.90
87116 <1% 43 $342.43
82340 <1% 88 $340.92
87653 <1% 13 $319.53
83529 <1% 31 $314.78
83935 <1% 78 $310.22
80162 <1% 26 $276.00
85660 <1% 55 $222.50
88280 <1% 13 $211.72
80235 <1% 13 $205.74
82530 <1% 17 $193.52
86707 <1% 26 $190.17
82747 <1% 15 $176.15
86709 <1% 28 $163.98
80183 <1% 18 $161.34
86060 <1% 29 $153.92
87181 <1% 25 $136.39
82365 <1% 12 $135.08
82384 <1% 12 $133.15
80360 <1% 14 $106.95
80156 <1% 12 $100.25
85384 <1% 12 $88.35
80051 <1% 15 $86.02
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 209 $68.78
89055 <1% 15 $66.00
89125 <1% 12 $53.75
82438 <1% 12 $49.24
89050 <1% 14 $40.46
84133 <1% 12 $39.48
84157 <1% 14 $34.98
89051 <1% 12 $34.48
82945 <1% 14 $33.82
0753T 0% 522 $0.00
80321 0% 128 $0.00
81490 0% 12 $0.00
80372 0% 17 $0.00
0064U 0% 28 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHILLERO, ANTHONY (DIRECTOR, FP&A)
Same official

Other billing entities under SCHILLERO, ANTHONY

Full network →
ProviderLocationPaid
University Hospitals Cleveland Medical CenterCleveland, OH$156.83M
University Hospitals Cleveland Medical CenterCleveland, OH$76.72M
Emh Regional Medical CenterElyria, OH$41.46M
Robinson Health System, INC.Ravenna, OH$26.26M
Uh Regional HospitalsChardon, OH$23.17M
University Hospitals Ahuja Medical Center, INCBeachwood, OH$21.13M
Parma Community General Hospital AssociationParma, OH$15.68M
University Hospitals ST. John Medical CenterWestlake, OH$11.77M
Samaritan Regional Health SystemAshland, OH$10.39M
University Hospitals Geneva Medical CenterGeneva, OH$9.85M
University Hospitals Home Care Services INCWarrensville Heights, OH$7.63M
University Hospitals Conneaut Medical CenterConneaut, OH$5.65M
University Hospitals Home Care Services INCWarrensville Heights, OH$4.12M
University Hospitals Cleveland Medical CenterCleveland, OH$2.88M
Uh Regional HospitalsChardon, OH$2.85M
University Hospitals Home Care Services INCWarrensville Heights, OH$1.36M
University Hospitals Critical Care Transport LLCShaker Heights, OH$309K
University Hospitals Cleveland Medical CenterCleveland, OH$101K
University Hospitals Laboratory Services FoundationCleveland, OH$58K
University Hospitals ST. John Medical CenterWestlake, OH$49K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.